Icon

Enact Holdings Inc Stock Analysis and Price Target COMMON STOCK | Specialty Chemicals | NSD

stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 27.59

+0.05 (+0.18)%

USD 0.25B

0.17M

USD 29.50(+6.92%)

USD 27.50 (-0.33%)

Icon

ACT

Enact Holdings Inc (USD)
COMMON STOCK | NSD
USD 27.59
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.25B

USD 27.50 (-0.33%)

USD 27.59

Enact Holdings Inc Stock Forecast

Show ratings and price targets of :
USD 29.50
(+6.92%)

Based on the Enact Holdings Inc stock forecast from 2 analysts, the average analyst target price for Enact Holdings Inc is USD 29.50 over the next 12 months. Enact Holdings Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Enact Holdings Inc is Bullish , which is based on 7 positive signals and 3 negative signals. At the last closing, Enact Holdings Inc’s stock price was USD 27.59. Enact Holdings Inc’s stock price has changed by -0.76% over the past week, +2.76% over the past month and +13.35% over the last year.

No recent analyst target price found for Enact Holdings Inc
No recent average analyst rating found for Enact Holdings Inc

Company Overview Enact Holdings Inc

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Hol...Read More

https://www.alzchem.com

Dr.-Albert-Frank-Strasse 32, Trostberg, Germany, 83308

1,497

December

EUR

Germany

Adjusted Closing Price for Enact Holdings Inc (ACT)

Loading...

Unadjusted Closing Price for Enact Holdings Inc (ACT)

Loading...

Share Trading Volume for Enact Holdings Inc Shares

Loading...

Compare Performance of Enact Holdings Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ACT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Enact Holdings Inc (Sector: Specialty Chemicals )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
GIVN
Given Imaging Ltd 0.00 (0.00%) USD30.13B 34.60 25.05

ETFs Containing ACT

Symbol Name ACT's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Enact Holdings Inc (ACT) Stock

Based on ratings from 2 analysts Enact Holdings Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Bullish . The stock has 1 buy, sell and 1 hold ratings.

ACT stock's dividend yield is 4.41%. Our analysis grades ACT stock's dividend yield at A-. This means that ACT stock's dividend yield is above 91% of the stocks in the Specialty Chemicals sector in the NSD exchange. Based on this ACT may be a good dividend stock for its sector.

Based on targets from 2 analysts, the average taret price for ACT is USD 29.50 over the next 12 months. The maximum analyst target price is USD 30 while the minimum anlayst target price is USD 29.

ACT stock's Price/Earning ratio is 8.09. Our analysis grades ACT stock's Price / Earning ratio at D. This means that ACT stock's Price/Earning ratio is above 36% of the stocks in the Specialty Chemicals sector in the NSD exchange. Based on this ACT may be fairly valued for its sector

The last closing price of ACT's stock was USD 27.59.

The most recent market capitalization for ACT is USD 0.25B.

Based on targets from 2 analysts, the average taret price for ACT is projected at USD 29.50 over the next 12 months. This means that ACT's stock price may go up by +6.92% over the next 12 months.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...